Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
292 results found
2026
Recommendations for pneumococcus 2026
Americas Pneumococcal disease
Download:
2026
Recommendations on pneumococcal vaccination to at-risk groups
Recommendation Europe Sweden Risk group Pneumococcal disease
Download:
2026 ∙ STIKO
Update of the STIKO recommendation on vaccination against pneumococcal disease for children and adolescents with risk factors aged ≥ 2 to 17 years
Recommendation Europe Germany children adolescents Risk group Pneumococcal disease
Download:
2025 ∙ Vink, K. Kusters, J. Wallinga, J.
Chrono-optimizing vaccine administration: a systematic review and meta-analysis
Adults Older adults COVID-19 Influenza Hepatitis B Hepatitis A Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Fletcher, M. A. Okasha, O. Baay, M. Syrochkina, M. Hayford, K.
Complicated pneumococcal pneumonia in the era of higher-valent pneumococcal conjugate vaccines: a systematic literature review and meta-analysis, 2001-2022
All age groups Pneumococcal disease Administration Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Cao, B. K. Hanifa, R. S. Nguyen, T. P. Postma, M. J. van der Schans, J.
Economic evaluations of vaccines against respiratory infections in adults in Southeast Asia: A systematic review
South-East Asia Western Pacific Adults Older adults Influenza COVID-19 Pneumococcal disease Varicella Pertussis Economic aspects
Rating:
Not applicable
2025 ∙ Dunne, E. M. Hong, L. Althouse, B. M. Hayford, K. Jodar, L. Gessner, B. D. Theilacker, C.
Effectiveness of a Single Dose of Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Children: A Systematic Literature Review
Newborn Children Adolescents Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Bulkhi, A. Khadawardi, H. A. Dairi, M. S. Alwafi, H. Alim, H. M. Turkistani, Y. A. Almoallim, H. M. Alghamdi, I. A. Alqashqri, H. S. Obaid, M. S. Alkhotani, A. M. A. Alhazmi, A. S. H. Adly, H. M. Zaini, R. Abdulkhaliq, A. A. Saleh, S. A. K. Hariri, N. H. Khan, A. A. Alamri, F. A. Garout, M. A.
Effectiveness of pneumococcal vaccination in reducing hospitalization and mortality among the elderly: A systematic review and meta-analysis
Adults Older adults Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Low
2025 ∙ Chang, C. Y. Nasreen, S. Sadarangani, M. Aquino, K. Cragg, J. J. Marra, F.
Effectiveness of vaccine dosing schedules for pneumococcal invasive disease in children: A systematic review and meta-analysis
Newborn Children Adolescents Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Low
2025 ∙ Nimpa, M. M. Ntambue, A. Ngandu, C. Danovaro-Holliday, M. C. Bita Fouda, A. Cikomola, A. M. W. Mukendi, J. C. Mwamba, D. Aluma, A. D. L. Yapi, M. D. Nikiema, J. B. Hama Sambo, B. Ishoso, D. K.
Effects of Pneumococcal Vaccination in Children Under Five Years of Age in the Democratic Republic of Congo: A Systematic Review
Africa Newborn Children Pneumococcal disease Efficacy/effectiveness Administration
Rating:
Critically low
Loading...